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SUMMARY
Colonic surgery is associated with major disturbances to patients’ fluid balance as a 
result of pre-operative starvation, intra-operative blood loss, insensible losses, and 
post-operative ‘third space’ losses. In the post-operative period, junior surgeons are 
well trained to manage oliguria, but have little experience of the management of 
post-operative polyuria. Nephrogenic diabetes insipidus occurs in 12% of patients 
on lithium therapy and may present in the immediate post-operative period with 
massive polyuria, profound dehydration and life threatening hypernatraemia, as 
patients are unable to ingest large volumes of fluid orally. We report two cases, one 
life threatening, of lithium induced nephrogenic diabetes insipidus (LINDI) which 
presented in the early postoperative period after emergency colonic surgery whilst 
the patients were denied oral intake. The first patient attained a peak serum sodium 
concentration of 185mmol/l and required ventilation after a respiratory arrest. We 
suggest any surgical patient who describes a history of bipolar disorder or lithium 
therapy should be questioned directly to ascertain confirmatory features of LINDI, 
and have post-operative polyuria treated with aggressive fluid replacement.
INTRODUCTION
Accurate fluid balance and maintenance of an 
acceptable urine output by intravenous fluid therapy 
is a cornerstone of good perioperative surgical care 
and is well known to junior surgeons throughout 
the world. Although surgical texts and courses (1,2) 
cover the management of post-operative oliguria in 
detail, there is little in the surgical literature about the 
management of postoperative polyuria. Nephrogenic 
diabetes insipidus, when the kidney cannot 
concentrate the urine, is a common cause of polyuria– 
it may be inherited or acquired, with the commonest 
acquired aetiology being the previous or continuing 
use of lithium salts, commonly prescribed as a mood-
stabilising agent in bipolar disorder. Lithium-induced 
nephrogenic diabetes insipidus (LINDI) occurs in up 
to 12% of patients taking lithium and may persist 
even after withdrawal of the treatment (3,4). Patients 
typically compensate by drinking huge quantities of 
fluids in what becomes a normal part of daily life for 
them. Failure of surgical staff to recognise the potential 
for profound perioperative dehydration in LINDI 
because of restriction of oral fluid intake may have 
life–threatening consequences from hypernatraemia, 
hyperosmolar coma or cardiovascular collapse. We 
present two cases of LINDI in surgical patients, 
one of which was life-threatening, and discuss the 
management of this uncommon condition and how 
these complications may be avoided. 
CASE REPORTS
Case 1: A 59 year old woman was admitted as an 
emergency with large bowel obstruction from a 
sigmoid adenocarcinoma. She was previously fit 
and well apart from hypothyroidism and bipolar 
disorder for which she had taken lithium carbonate 
for more than 20 years. At laparotomy, a left 
hemicolectomy with end to end anastomosis and 
a left salpingo-oophorectomy for an incidental 
ovarian mass was performed. Within 24 hours of 
surgery she was confused and had passed 7000ml 
of dilute urine, her serum sodium had risen 
to 176mmol/l with a normal serum potassium 
level and she had an elevated serum creatinine 
of 215mmol/l. She was receiving no fluid orally 
and had received only 2700mls of intravenous 
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crystalloid (2 litres of Ringer’s lactate and 700 ml 
0.9% sodium chloride solution) as replacement. Her 
lithium levels were within the therapeutic range. 
Unsure of the cause of the patient’s confusion and 
worsening fluid and electrolyte status an urgent 
medical consultation was organised and a diagnosis 
of LINDI was made; rehydration with 0.9% saline at 
250ml/hr was commenced after transfer to the High 
Dependency Unit (HDU). During the following 
day she remained confused and her sodium rose to 
185mmol/l, serum osmolality was 391 mOsm/kg 
(normal range 282-295) and urine osmolality of 166 
mOsm/kg (normal range 500-800). She continued to 
produce 100-350ml/hr of urine and her calculated 
free water deficit was 8.5 litres over 48 hours. A 
trial of subcutaneous desmopressin (2mcg once 
daily) was unsuccessful in reducing the volume 
of polyuria, and fluid replacement continued with 
0.18%saline/5% dextrose solution.
 On the fifth post-operative day she suffered 
a respiratory arrest and required intubation and 
ventilation for 48 hours. Over this period her serum 
electrolytes returned to normal with continued 0.18% 
saline/5% dextrose solution resuscitation. After 
extubation she resumed oral intake and on direct 
questioning admitted to routinely drinking 2-3 litres 
of carbonated drinks each night to try and quench her 
thirst. She was discharged on day 17 with an ongoing 
polydipsia and high volume oral fluid intake. She 
remained well when reviewed in clinic six weeks later 
with normal serum urea and electrolytes and a mildly 
raised serum osmolality of 317 mOsm/kg. Her serum 
sodium concentration and urine output over the course 
of her admission are shown in Figure 1. 
Figure 1
Serum sodium trend, Case 1
Figure 2
Mean urine output, Case 1
Legends
Events 
Day 1: Rehydration with 0.9% saline 6 hourly
Day 2: Rehydration with 5% dextrose, trial of 2 micrograms DDAVP
Day 3: Rehydration with 5% dextrose specifically replacing urinary losses
Day 4: Trial of 2 micrograms DDAVP; respiratory arrest due to mucus plug
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Case 2: A 71 year old lady was admitted as an 
emergency with a history of constipation, severe 
abdominal pain and distension resulting in an 
emergency sigmoid colectomy for perforated sigmoid 
volvulus. She had a past medical history of mild 
chronic renal failure and bipolar disorder previously 
treated with lithium which had been discontinued 
many years prior to her presentation. She also took 
low dose desmopressin for previously suspected 
LINDI. Despite a planned admission to the High 
Dependency Unit (HDU) post-operatively, she still 
developed polyuria within 48 hours of ceasing oral 
intake (urine output 200 – 350 ml/hour) and a 2 litre 
fluid deficit. Her serum sodium was 151 mmol/l with 
a mild hyperchloraemic acidosis, serum osmolality of 
322 mOsm/kg and urine osmolality of 173mOsm/kg. 
Ringer’s lactate infusion was changed to 5% dextrose 
and her desmopressin increased to 1mcg four times 
daily subcutaneously and then 10mcg four times daily 
intranasally without appreciable effect. Two days 
later her serum sodium remained at 151mmol/l and 
she remained polyuric (>6000 ml/day), but she had 
recommenced oral fluid intake. By the eighth post-
operative day her serum sodium had normalised; 
she was discharged well but polyuric five weeks 
after admission.
DISCUSSION
Polyuria and secondary polydipsia producing huge 
volumes of unconcentrated urine with a resultant 
serum concentration and hypernatraemia are the 
hallmarks of nephrogenic diabetes insipidus. It may 
rarely be due to inherited conditions but is usually 
acquired, most commonly from lithium therapy.
 Lithium salts have long been recognised as a 
cause of nephrogenic diabetes insipidus by rendering 
the distal tubule and collecting duct of the nephron 
completely, or more usually partially, insensitive to the 
concentrating action of vasopressin. They also down-
regulate aquaporins, integral membrane proteins that 
are ‘pores’ through which water is normally resorbed 
(5,6). These channels are impermeable to ions and 
are, in the healthy state, regulated by endogenous 
vasopressin. The effects of lithium on the tubule may 
persist for many years following its cessation and 
may be due to the induction of chronic glomerular 
and interstitial nephropathies (7). 
 The diagnosis of LINDI depends on a careful 
history and examination as well as the logical 
measurement of biochemical parameters in response 
to water deprivation and vasopressin administration. 
The relevant drug history confirms lithium therapy 
as well as possible polydipsia and polyuria. A 
positive water deprivation test is then performed 
which confirms the patient’s inability to concentrate 
urine suggesting diabetes insipidus. This involves 
measuring patients’ weight, electrolytes, and serum 
and urine osmolalities before and after depriving 
them of water for a variable period of time (usually 12 
hours). In the healthy state, urine osmolality should 
at least double. Following this, the aetiology of the 
diabetes insipidus is determined by demonstrating 
the patient’s sensitivity to vasopressin. In addition 
to a negative water deprivation test, patients with 
LINDI typically have a less than 10% increase in 
urine osmolality after a trial of vasopressin (8).
 The treatment of established LINDI is restitution 
of intravascular volume whilst attempting to stimulate 
renal concentration of urine. Hypernatraemia, which 
is initially due to serum concentration from the loss of 
free water, is potentially exacerbated by resuscitation 
with normal saline, as the kidney cannot eliminate 
the additional sodium load (6). Dextrose or dextrose 
saline solution is the intravenous fluid of choice whilst 
hypernatraemia persists. 
 As the underlying pathophysiology is a 
partial or complete insensitivity to endogenous 
vasopressin, the administration of exogenous 
vasopressin analogues may only be beneficial in 
those cases where insensitivity is partial – it had no 
effect in either of our cases. Other pharmacological 
interventions include the use of non-steroidal anti-
inflammatory drugs (NSAIDS) and, paradoxically, 
diuretics. NSAIDs reduce prostaglandin-mediated 
glomerular filtration and hence reduce free water 
loss (6,9). The exact mechanisms by which thiazide 
diuretics and amiloride act in LINDI is unclear. 
Amiloride may decrease the effect of lithium on the 
collecting tubules and render them more sensitive 
to vasopressin (10,11). Thiazide diuretics may 
decrease polyuria by increasing renal sodium losses, 
contracting extracellular fluid volume and decreasing 
the glomerular filtration rate. Furthermore, both 
thiazide diuretics and amiloride may increase the 
expression of aquaporins and sodium channels in the 
distal tubule, enhancing water resorption (5,12,13). 
 Most patients with LINDI, aware of the diagnosis 
or not, maintain health by regularly drinking 
abnormally large volumes of fluid, which becomes 
such a part of their daily life that they may well not 
volunteer this information during routine surgical 
clerking. We suggest that any patient who gives a 
history of past or present lithium therapy, or bipolar 
disorder that may have previously been treated with 
lithium, should be asked directly about symptoms of 
polyuria and polydipsia. Pre-operative recognition 
of the condition should prompt more aggressive 
intravenous fluid replacement for these patients when 
denied oral fluids, more frequent estimation of serum 
electrolytes and closer peri-operative monitoring to 
reduce the risks of hypernatraemia and hypersomolar 
coma.
In conclusion, a history of bipolar disorder or 
lithium therapy should necessitate direct enquiry 
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about the presence of polyuria and polydipsia to 
avoid postoperative complications. Unexpected 
post-operative polyuria should prompt the early 
consideration of a diagnosis of LINDI and institution 
of aggressive intravenous rehydration, using dextrose 
solutions in the face of hypernatraemia. In the 
established cases of LINDI, desmopressin may be 
ineffective and the use of amiloride, thiazide diuretics 
or NSAIDs should be considered.
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